The influence of adjuvant chemotherapy dose intensity on overall survival in resected colon cancer: A multicentered retrospective analysis

Colorectal cancer remains the second leading cause of cancer death in North America. Fluorouracil and oxaliplatin based adjuvant chemotherapy for resected colon cancer (CC) reduces cancer recurrence, but also causes significant toxicity requiring dose reductions.